文献速递妇科生殖医学

肠道与生殖道微生物群及雌激素代谢组在内异症、不孕与慢性盆腔痛中的作用

The role of gut and genital microbiota and the estrobolome in endometriosis, infertility and chronic pelvic pain.
PubMed 文献 · Hum Reprod Update · 2021-01-01

本文综述了微生物组与雌激素代谢组在内异症、不孕和慢性盆腔痛中的潜在关系,检索2002至2021年文献,纳入28项临床研究和6项动物研究。多数研究显示细菌性阴道病相关细菌及乳杆菌耗竭与内异症和不孕相关,动物研究支持肠道微生物群与内异症的双向关系,但研究方法学存在局限。

要点

  • 多数研究(23/28)显示阴道加德纳菌等细菌性阴道病相关细菌及乳杆菌耗竭与内异症和不孕相关。
  • 动物研究(6/6)支持肠道微生物群与内异症发生和进展之间存在双向关系。
  • 目前无明确与内异症相关的特定微生物组成共识,且无研究同时纳入内异症合并不孕或慢性盆腔痛。

核心结论

  • 有证据表明肠道或生殖道菌群失调与多种妇科疾病相关,越来越多的数据支持微生物组与内异症和不孕之间存在关联。
  • 这些微生物组可能在肠-脑轴中发挥作用,进一步支持其与内异症相关症状谱(包括不孕和慢性盆腔痛)的推定关联。
  • 本综述强调需要更严谨和透明的方法学与对照、该领域的一致性,以及纳入疾病和对照参与者的关键人口学和临床特征。

研究设计与样本

  • 检索PubMed数据库,关键词包括内异症与微生物组、不孕与微生物组、盆腔痛与微生物组、体外受精与微生物组、内异症与不孕。
  • 纳入2002至2021年发表的符合条件的临床和临床前动物试验,共纳入28项临床研究和6项动物研究。

主要发现

  • 在人类和动物研究中,内异症组的细菌均富集,但关于与内异症相关的特定微生物组成尚无明确共识,且无研究纳入内异症合并不孕或慢性盆腔痛。
  • 在多数研究(23/28)中,宫颈阴道微生物群中的细菌性阴道病相关细菌和乳杆菌耗竭与内异症和不孕相关。
  • 动物研究(6/6)支持肠道微生物群与内异症发生和进展之间的双向关系。
  • 子宫内膜研究的解读因多种方法学因素而受限,本综述对此进行了讨论。
  • 关于抗生素使用、年龄、种族/民族、绝经状态和样本采集时间与内异症诊断关系的元数据未被一致报告。

关键数值与推荐

  • 多数研究(23/28)报告细菌性阴道病相关细菌和乳杆菌耗竭与内异症和不孕相关。
  • 动物研究(6/6)支持肠道微生物群与内异症发生和进展之间的双向关系。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 关于与内异症相关的特定微生物组成尚无明确共识。
  • 无研究纳入内异症合并不孕或慢性盆腔痛。
  • 子宫内膜研究的解读因多种方法学因素而受限。
  • 关于抗生素使用、年龄、种族/民族、绝经状态和样本采集时间与内异症诊断关系的元数据未被一致报告。
  • 需要更严谨和透明的方法学与对照、该领域的一致性,以及纳入疾病和对照参与者的关键人口学和临床特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endometriosis is a chronic, burdensome condition that is historically understudied. Consequently, there is a lack of understanding of the etiology of the disease and its associated symptoms, including infertility and chronic pelvic pain (CPP). Endometriosis development is influenced by estrogen metabolism and inflammation, which are modulated by several factors including the microbiome and the estrobolome (the collection of genes encoding estrogen-metabolizing enzymes in the gut microbiome). Therefore, there is increasing interest in understanding the role of microbiota in endometriosis etiology. OBJECTIVE AND RATIONALE: To date, there is no cure for endometriosis and treatment options often are ineffective. This manuscript will review the potential relationship between the microbiome and endometriosis, infertility and CPP and highlight the available data on the microbiome in relation to endometriosis and its related symptoms. The overarching goal of this manuscript is to inform future microbiome research that will lead to a deeper understanding of the etiology of the disease and possible diagnostic modalities and treatments. The potential impact of the microbiome on estrogen regulation modulated by the estrobolome, as well as inflammation and other endometriosis-promoting mechanisms within the genital tract, will be reviewed. The methodological limitations of microbiome-related studies will be critically assessed to provide improved guidelines for future microbiome and clinical studies. SEARCH METHODS: PubMed databases were searched using the following keywords: endometriosis AND microbiome, infertility AND microbiome, pelvic pain AND microbiome, IVF (in-vitro fertilization) AND microbiome, endometriosis AND infertility. Clinical and preclinical animal trials that were eligible for review, and related to microbiome and endometriosis, infertility or CPP were included. All available manuscripts were published in 2002-2021. OUTCOMES: In total, 28 clinical and 6 animal studies were included in the review. In both human and animal studies, bacteria were enriched in endometriosis groups, although there was no clear consensus on specific microbiota compositions that were associated with endometriosis, and no studies included infertility or CPP with endometriosis. However, bacterial vaginosis-associated bacteria and Lactobacillus depletion in the cervicovaginal microbiome were associated with endometriosis and infertility in the majority (23/28) of studies. Interpretation of endometrial studies is limited owing to a variety of methodological factors, discussed in this review. In addition, metadata outlining antibiotic usage, age, race/ethnicity, menopausal status and timing of sample collection in relation to diagnosis of endometriosis was not consistently reported. Animal studies (6/6) support a bidirectional relationship between the gut microbiota and endometriosis onset and progression. WIDER IMPLICATIONS: There is evidence that a dysbiotic gut or genital microbiota is associated with multiple gynecologic conditions, with mounting data supporting an association between the microbiome and endometriosis and infertility. These microbiomes likely play a role in the gut-brain axis, which further supports a putative association with the spectrum of symptoms associated with endometriosis, including infertility and CPP. Collectively, this review highlights the demand for more rigorous and transparent methodology and controls, consistency across the field, and inclusion of key demographic and clinical characteristics of disease and comparison participants. Rigorous study designs will allow for a better understanding of the potential role of the microbiome in endometriosis etiology and the relationship to other disorders of the female reproductive tract.

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. Salliss ME, Farland LV, Mahnert ND, et al. The role of gut and genital microbiota and the estrobolome in endometriosis, infertility and chronic pelvic pain. Hum Reprod Update. 2021. PMID: 34718567. doi:10.1093/humupd/dmab035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。